Life Sciences & Pharmaceuticals

Read our latest alert on California’s SB 41 for a practical compliance roadmap—implementation timeline, immediate next steps, a 30-day action checklist, and ongoing planning guidance to align PBM practices by January 1, 2026.

Read Hinshaw partner Michael Dowell's article in the October 2025 edition of the U.S. Pharmacist, which explores how telepharmacy and remote dispensing are being used to combat the rising number of pharmacy closures and pharmacy deserts in underserved urban and rural areas.

Learn how OIG Advisory Opinion 25-03 safeguards and compliance best practices can help providers expand their telehealth services while minimizing regulatory risk.

Discover the key compliance challenges and legal risks in the rapidly growing medical spa industry, with a focus on California regulations and practical guidance for ensuring patient safety and business success.

Pharmacies, wholesalers, third-party logistics providers, outsourcing facilities, clinics, and pharmacists must obtain the California State Board of Pharmacy’s (the “Board”) approval or otherwise notify the Board about changes in ownership, corporate structure, staffing, and the scope of services provided. Reportable changes can be grouped into the following three areas:

Hinshaw & Culbertson LLP today announced that Frank A. Mazzagatti has joined the firm's Health Care industry group as a partner in the New York office. Mazzagatti brings extensive experience with health care regulatory compliance, licensing matters, and transactions.

The law firm of Hinshaw & Culbertson LLP is pleased to announce that Scott Seaman—Chicago-based partner and co-chair of Hinshaw's global Insurance Services Practice Group—has been named a Top Author in the Insurance category of the 2024 JD Supra Readers' Choice Awards. This marks the fourth consecutive year Seaman was named a Top Insurance Author in the JD Supra Readers' Choice Awards. Honorees were selected from a pool of 2,600 insurance law authors.  

The 340B Drug Program requires pharmaceutical manufacturers participating in the Medicaid program to provide covered outpatient drugs at significantly reduced prices to certain health care organizations and programs, referred to as "Covered Entities" [42 United States Code (USC) §256b]. 

Pharmacy employees at some CVS and Walgreens stores, including pharmacists, technicians, and support staff, recently walked off of their jobs to protest insufficient staffing and dangerous workloads that they claim jeopardize patient safety.

In a legal column published by U.S. Pharmacist, Hinshaw partner Michael Dowell discussed the impact of the U.S. Supreme Court's decision in the consolidated case Ruan v. United States and Kahn v. United States. The Ruan decision ruled that the Drug Enforcement Administration (DEA) must prove beyond a reasonable doubt that a prescriber knowingly or intentionally issued a prescription that they knew or intended was not for a legitimate medical purpose in order to subject that physician to criminal penalties under the Controlled Substances Act (CSA). 

The U.S. law firm of Hinshaw & Culbertson LLP is pleased to announce that Hinshaw partner Michael Dowell has been recognized as a "Top Health Care Lawyer" in California by The Daily Journal. The list honors leading California attorneys who focus on health care litigation, transactions, and counseling, with honorees selected by Daily Journal editors from nominations submitted by lawyers statewide. The Los Angeles and San Francisco Daily Journals provide information on the legal industry, real estate and general business in California.

Hinshaw partner Michael Dowell recently authored a byline published by U.S. Pharmacist titled "State PBM Regulations Protecting Community Pharmacies." In the article, Dowell discusses state regulatory scrutiny of pharmacy benefit managers (PBMs), a legal challenge to that scrutiny on federal preemption grounds, and the general outlook for state regulation in the future.